The systematic evaluation of the consequences of using health technologies
The health technology team at CHERE undertakes economic evaluations of health interventions and technologies, including safety, effectiveness, economic impacts and ethical issues associated with the introduction of health technologies. We have considerable experience in advanced economic evaluation methods and applying these to evaluate medical services, pharmaceutical products and public health interventions. Our work includes the development of economic models and evaluation of new technologies for the Medical Services Advisory Committee and the Pharmaceutical Benefits Advisory Committee. The results play a significant role in informing decision-making in the healthcare sector by ensuring that policy-makers have the necessary information to understand the comparative harms, benefits and costs of new technologies.
For more information: Professor Stephen Goodall, Assoc Prof Richard De Abreu Lourenco